About Matthew Lipscomb
Matthew Lipscomb is a director at DMC Biotechnologies.
Matthew Lipscomb first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Matthew Lipscomb in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Matthew Lipscomb works with at each company, as listed on that company's latest Form D.
DMC Biotechnologies, Inc. · Form D, Dec 30, 2025
RM
Rob van der Meij
Director
JY
Josh Yelen
Executive officer
AC
Alastair Cooper
Director
KJ
K'Lynne Johnson
Director
JF
Jim Flatt
Chief Executive Officer and director
DC
Doug Cameron
Director
JB
Josko Bobanovic
Director